FRCPath Haem Part 1 MCQ-Oncology 356

A 45yr-old pt with relapsed Hodgkin lymphoma receives antibody therapy that enhances T-cell immune response by blocking inhibitory signalling. Targeted antigen?

• CD30
• CD20
• CD19
• CTLA-4

See All Options

Want to read more?

Subscribe to hematomorph.com to keep reading this exclusive post.

Subscribe Now